Focus: Subtype-selective ATP-sensitive potassium channel (KATP) inhibitors for migraine
Cephagenix is a life sciences company focused on Subtype-selective ATP-sensitive potassium channel (KATP) inhibitors for migraine.
No open positions listed yet.